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Abstract  
 
Background Children born after medically assisted reproduction (MAR) are at higher risk of 
adverse birth outcomes than naturally conceived children. It is not known to what extent the 
excess risk should be attributed to harmful effects of the treatment or to pre-existing parental 
characteristics that confound the association.   
Methods We analysed birth weight, gestational age, risk of low birth weight, and risk of 
preterm birth among MAR- and naturally conceived children using Finnish population 
registers covering 65,634 children born in 1995-2000. First, we estimated the differences in 
birth outcomes by mode of conception in the general population using standard multivariate 
methods that controlled for observed factors (e.g., multiple birth, birth order, and parental 
socio-demographic characteristics). Second, we used a sibling-comparison approach that has 
not been used before in MAR research. We compared MAR-conceived children to their 
naturally conceived siblings, and thus controlled for all observed and unobserved factors 
shared by siblings. The latter analysis included 1245 children. 
Findings MAR-conceived children had worse outcomes than naturally conceived children for 
all outcomes, even after adjustments for observed child and parental characteristics (e.g., 60gr 
[95% CI: -34 to -86] lower birth weight; 2.2-percentage point [95% CI: 1·1 to 2·2] increased 
risk of preterm delivery). In the sibling comparison, the gap in birth outcomes was attenuated, 
such that the relationship between MAR and adverse birth outcomes was statistically and 
substantively weak for all outcomes (e.g., 31gr [95% CI: -22 to 85] lower birth weight; 1.6 
percentage points [95% CI: -1·3% to 4·4%] increased risk of preterm delivery).  
Interpretation MAR-conceived children face an elevated risk of adverse birth outcomes. 
However, our results indicate that this increased risk is largely attributable to factors other 
than the MAR treatment itself.  
Funding European Research Council, the Academy of Finland, and the Signe and Ane 
Gyllenberg Foundation.  
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Research in context 
Evidence before this study  
We searched for studies analysing the association between Medically Assisted Reproduction 
and birth outcomes within families who had at least one child conceived through MAR and 
one child conceived naturally, published in any language up until March 2018 (with no 
specified earliest date). We searched in PubMed and Google Scholar using relevant terms 
(“Medically Assisted Reproduction”, “Assisted Reproductive Technology”, “birth 
outcomes”, “low birth weight”, “preterm”, “siblings”, “within family”). We found only three 
studies that compared MAR- and naturally conceived children from the same families. These 
studies, which reported mixed findings, suffered from two major limitations. First, they relied 
on random-effects models, which are biased when unobserved random effects (e.g., 
measuring health) are correlated with observed covariates (e.g., maternal age, socioeconomic 
status). Second, they focused on children conceived through IVF only, and included children 
born after other fertility treatments (ovulation induction or artificial insemination) in the 
naturally conceived group. This approach may have biased the estimated MAR effects 
towards zero, as children conceived through other MAR treatments have worse birth 
outcomes than naturally conceived children.  
 
Added value of this study  
The current study considered all MAR-conceived children, and adopted a sibling-comparison 
model with a fixed-effects specification that is more appropriate (than random-effects 
models) for determining whether the MAR treatment had an independent effect on birth 
outcomes, as it fully controlled for unobserved parental characteristics shared by siblings. 
Moreover, it relied on a uniquely high-quality register dataset that was large enough to 
facilitate sibling comparisons, free of loss to follow-up and self-report biases.  
 
Implications of all the available evidence  
As a group, children born after MAR are, in absolute terms, at increased risk of adverse birth 
outcomes. But the results of the current study indicate that this elevated risk is likely 
attributable to factors other than the treatment itself. Understanding the risks associated with 
MAR treatment is very important for couples considering using MAR treatment to conceive, 
physicians advising patients about the risks of MAR, and public health policy-makers. 
 
 
  
4 
 
Introduction 
Medically Assisted Reproduction (MAR) – i.e., reproduction brought about through 
treatments such as ovulation induction, artificial insemination, in vitro fertilization (IVF) or 
intracytoplasmic sperm injection (ICSI) with fresh/frozen embryo transfer – is one of the key 
achievements of reproductive medicine. The increasing number of children born after MAR, 
to date more than five million,
1
 has motivated research about its impact on the well-being of 
children.   
 
While previous studies have consistently found that children born after MAR have worse 
perinatal outcomes than children who were conceived naturally,
2-6
 the mechanisms 
underlying this well-established association are not fully understood. First, worse outcomes 
could be related to the rates of multiple births, which are 10-20 times higher in the MAR 
subpopulation than in the general population, and are strong predictors of adverse birth 
outcomes.
7
 Second, the association could be related to parental characteristics that predispose 
the parents to seek MAR treatments and to be at high risk of adverse birth outcomes, such as 
subfertility and advanced age, which are known risk factors for adverse birth outcomes.
4,8,9
 
However, the risk of adverse outcomes cannot be entirely attributed to multiple births, as 
singletons conceived through MAR are also at higher risk of adverse birth outcomes than 
singletons conceived naturally.
3,10
 Existing studies have also found that although subfertility 
might play a role it cannot be considered as the only explanation for the poorer outcomes of 
the MAR subgroup relative to the overall population and that being born to an older mother is 
not associated with worse birth outcomes among children conceived through MAR.
4,11
  
 
Consequently, the literature has suggested that some of the effects could be attributed to the 
MAR procedures themselves, 
4,12,13
 such as the freezing of embryos, the delayed fertilisation 
of the oocytes, and the hormonal treatments.
14
 However, establishing an independent effect 
requires isolating the effects of the MAR procedures from the multiple factors that might 
confound the association – many unobserved by the researcher. The majority of existing 
studies have analysed the association between MAR and birth outcomes by comparing MAR- 
and naturally conceived children in different families, and by adjusting for a limited set of 
observed characteristics.
3,4
 The results of such studies may suffer from bias due to residual 
confounding. For example, the health of the mother, which may influence the likelihood of 
adverse birth outcomes, is unlikely to be fully captured by observed control variables.  
 
This study is the first to analyse the potentially harmful effects of MAR treatment using a 
sibling-comparison approach, which enables us to account for all observed and unobserved 
parental characteristics shared by siblings.
15
 We used large-scale Finnish register data to 
analyse the association between MAR and birth outcomes within families in which at least 
one child was born after MAR and one child was conceived naturally. Three earlier MAR 
studies compared siblings, but these studies suffered from two major limitations. First, they 
relied on random-effects models, which are biased when unobserved random effects (e.g., 
measuring health) are correlated with observed covariates (e.g., socioeconomic status).
16
 
Second, they focused on children conceived through IVF only, and assigned children born 
after other fertility treatments to the naturally conceived group.
17-19
 We consider all MAR-
conceived children; adopt a sibling-comparison model with a fixed-effects specification that 
is best suited for establishing whether the MAR treatment has an independent effect on birth 
outcomes; and rely on a uniquely high-quality register dataset that is large enough to facilitate 
sibling comparisons, without loss to follow-up and self-report bias.  
 
Methods 
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Study population 
We used data from Finnish administrative registers covering a 20% random sample of 
households with at least one child aged 0–14 at the end of 2000. The linkages between 
different registers were carried out by Statistics Finland using personal identification 
numbers. We included birth cohorts 1995–2000 because the information  on whether the 
child was conceived through MAR or naturally was available from 1995 onwards.  
 
Birth outcomes 
Information on four birth outcomes was extracted from the Finnish Medical Birth Register 
(MBR): birth weight (in grams), gestational age at birth (in days), and indicators for low birth 
weight (LBW, less than 2500g at birth), and whether the child was preterm (less than 37 
weeks of gestation). 
 
Medically Assisted Reproduction (MAR)  
We identified children who were conceived through MAR from purchases of prescription 
medication using the method developed by Hemminki et al., which has been found to be 
reliable.
20
 There are four main MAR techniques (ovulation induction, artificial insemination, 
IVF and ICSI with fresh/frozen embryo transfers) with an associated common pattern of 
fertility drugs. We retrieved from the National Prescription Register information on all 
prescription medication purchases from Finnish retail pharmacies, regardless of whether the 
medication was prescribed in the public or private sector. The Prescription Register provides 
information on the day of purchase, the name and class of the drug, and the size and quantity 
of packages. By combining each woman’s purchases of fertility drugs with her child’s date of 
birth (retrieved from the MBR), we were able to identify children conceived through MAR.  
 
Control variables 
We considered a range of child and parental characteristics that are associated with both 
conceiving through MAR and with the risk of adverse birth outcomes. The child 
characteristics retrieved from the MBR were sex, multiple birth, and birth order (1, 2, 3, or 
higher of live births).  
 
The mother’s characteristics included mother’s age at birth (continuous), whether the mother 
smoked during pregnancy (binary), deciles of household income, highest level of education in 
the household (tertiary or below), and the marital status of the parents. Because the aim of the 
study was to isolate the effects of MAR from these of confounders, the models did not 
include adjustments for mediators – e.g, gestational age or gestational hypertension – that 
could be on the causal pathway between MAR and birth outcomes. 
 
Statistical analyses 
We evaluated the association between MAR and birth outcomes using two approaches. The 
standard approach used in the literature consists of analysing the association between MAR 
and birth outcomes by comparing children born in different families. In order to account for 
confounders, these models included controls for observed child and parental characteristics. 
We refer to these models as between-family comparisons.  
 
The alternative approach was based on comparing siblings born to the same parents, but 
conceived either naturally or through MAR; we refer to these models as within-family 
comparisons. Also known as sibling fixed effects, the within-family model includes an 
indicator for each sibling group, and identifies the association between MAR and birth 
outcomes from variation between siblings.
15
 The main advantage of this model is that it fully 
6 
 
accounts for unobserved family characteristics shared by siblings. These unobserved 
characteristics may, for example, include subfertility, which predisposes a couple to seek 
MAR treatment to conceive and to experience adverse birth outcomes. Observable 
characteristics that are not shared by siblings and vary over time, such as family income at 
the year of birth, were adjusted for as in standard regression analyses. We did not control for 
education and marital status of parents, which show little variation between siblings. 
  
We estimated four regression models using Stata 14 for both the between- and within-family 
approaches. We estimated linear models on the continuous outcomes (birth weight and 
gestational age) and linear probability models on the binary outcomes (LBW and preterm 
birth), in which the model coefficients were interpretable as marginal effects.
15
 The baseline 
model documented the descriptive association between MAR and each of the outcomes. 
Model 1 introduced controls for the child’s sex and multiple birth, Model 2 introduced 
controls for birth order, and Model 3 introduced controls for parental characteristics.
4
  
 
Children born after MAR are more likely to be first-born or of lower birth orders than their 
naturally conceived siblings.
8,17,21
 Primiparity is associated with increased risk of adverse 
perinatal outcomes, and birth weight increases with increasing birth order
22
. Thus, birth order 
could partly explain the poorer birth outcomes of MAR-conceived children. To explore this 
possibility, we replicated the within-family analyses (baseline and Model 1) depending on 
whether the birth of the MAR-conceived child preceded (n=744) or followed (n=464) the 
birth of his/her naturally conceived sibling. For this last set of analyses, when the MAR-
conceived child was born in-between two natural conceptions or when a naturally conceived 
child was born in between two MAR births, we only considered the first two births and 
excluded the third (or higher order) birth (n=33). We also excluded families (n=2) in which 
two consecutive MAR-conceived births were followed by a natural conception, or in which 
two natural conceptions were followed by a MAR-conceived birth.  
 
Inclusion criteria and exclusions  
We excluded cases of prescription medication purchases in the special refund category, 
which indicates the use of fertility drugs to treat other diagnosed medical conditions, such as 
cancer. We excluded births to mothers younger than age 20 (n=1,862) or older than age 45 
(n=267) because it was unclear whether the women in these age groups were using the drugs 
for infertility or for other purposes. We dropped families with triplets (n=44). We kept in the 
analyses siblings who did not have the same father, as they were very small in number (n=4). 
Prevalence of missing data was negligible (the variable showing the highest level was 
smoking during pregnancy at 4%). The final sample included 65,723 children, 4% (n=2776) 
of whom were conceived through MAR. In 578 families, at least one child was conceived 
through MAR and one child was conceived naturally (n=1245). 
 
Previous studies using sib-ship designs 
Only three other studies have explored the association between MAR and birth outcomes 
using sib-ship designs. These studies relied on random-effects models. A key assumption for 
unbiased random-effects model is that the individual effects are uncorrelated with observed 
independent variables, an assumption that is often untenable.
16
 To overcome this limitation, 
we use fixed-effects models, which do not require any assumption about the correlation 
between unobserved fixed effects and observed independent variables, and are thus more 
appropriate to fully control for unobserved parental characteristics shared by siblings.
16
 Prior 
studies have also restricted the MAR category to IVF-conceived children only which could 
bias the MAR effects towards zero, as children conceived through other MAR treatments 
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have worse birth outcomes than naturally conceived children.
21
 To overcome this possible 
bias we included in the MAR group children who were conceived through IVF as well as 
other MAR techniques.  
 
Results 
Descriptive analyses 
In the between-family analyses, MAR-conceived children had worse birth outcomes than the 
naturally conceived children (table 1). For example, the prevalence of LBW was 3·5% 
(n=2,203) in the naturally conceived group and 12·8% (n=355) in the MAR-conceived group. 
MAR-conceived children were also more likely than naturally conceived children to be the 
first-born (61·6% (n=1,710) vs. 37·7% (n=23,731)), and almost 10 times more likely to be a 
multiple birth (20·7% (n=575) vs. 2·1% (n=1,322)). Compared to mothers of naturally 
conceived children, mothers of MAR-conceived children were, on average, older, better 
educated, and less likely to smoke during pregnancy.  
 
In the within-family comparisons, the differences in birth outcomes were reduced, but not 
eliminated. For example, 2·9% (n=18) of naturally conceived and 8·6% (n=54) of MAR-
conceived children were LBW. 
 
Regression results 
The between-family results showed that MAR children had significantly worse birth 
outcomes than naturally conceived children: on average, they were lighter and born earlier, 
and were more likely to be LBW and to be born preterm (Table 2, coefficients for the control 
variables presented in Web Tables 1-4). For example, MAR-conceived children were, on 
average, 265gr lighter (95% CI: -295 to -235) and 9.8 percentage points (95% CI: 8·1 to 
11·4) more likely to be preterm. The baseline associations were attenuated by around 60-70% 
when adjustments were made for sex and multiple births in Model 1; and by around 60-80% 
when a further adjustment was made for birth order in Model 2. However, in the fully 
adjusted Model 3, MAR-conceived children still had lower birth weight, increased risk of 
LBW, shorter gestation, and increased risk of preterm birth (e.g., on average 60gr (95% CI: -
85 to -34) lighter and 2·1 percentage points more likely to be preterm (95% CI: 1·1 to 3·2) 
than naturally conceived children).  
 
Our within-family comparison of MAR-conceived children with their naturally conceived 
siblings showed that the associations were weaker than in the between-family analyses. For 
example, in the baseline model, the difference in birth weight was 136g (95% CI: -188 to -
84), and the difference in preterm delivery was four percentage points (95% CI: 1·4 to 6·7). 
In the fully adjusted Model 3, the difference in birth weight was only 31g (95% CI: -85 to 
22), and the difference in preterm delivery was 1·6 percentage points (95% CI: -1·6 to 4·4). 
The patterns for gestational age and LBW were similar. In the fully adjusted within-family 
analysis, there was no evidence of a statistically significant association between MAR and 
birth any outcome (figures 1-4). These results were almost identical if we excluded multiple 
births from the analytical sample.  
 
MAR children born before their naturally conceived siblings had lower birth weight and 
increased probabilities of LBW and preterm delivery (Table 3 and Figure 5). However, 
among MAR-conceived children born after their naturally conceived siblings, the association 
was reversed for birth weight, and was much smaller and not statistically significant for LBW 
and preterm delivery. Following adjustments for the child’s sex and multiple births (Model 
1), MAR-conceived children were 163 gr (95% CI: -220 to -105) lighter if they were born 
8 
 
before their naturally conceived siblings, and 58gr (95% CI: -28 to 144) heavier if they were 
born after. Regardless of birth order, MAR-conceived children were, on average, born earlier 
than their naturally conceived siblings; but the risk of preterm birth was significantly higher 
only among MAR-conceived children born before their naturally conceived siblings.  
 
Discussion 
As a group, MAR-conceived children are at elevated risk of having low birth weight and 
being born preterm. This excess risk could be due to harmful effects of the treatment or to 
pre-existing parental characteristics that confound the association between MAR treatment 
and birth outcomes. Our analysis of birth outcomes in families with both MAR-conceived 
and naturally conceived children found only limited evidence that the excess risk could be 
attributed to the MAR treatment itself. When we compared MAR-conceived children to their 
naturally conceived siblings, we found smaller and, after adjustments for multiple births and 
birth order, both statistically and substantively negligible associations between MAR and 
birth outcomes.  
 
This study has several strengths. First, the dataset was large and allowed us to compare 
siblings conceived through MAR and naturally. Second, the data were not prone to self-
selection or self-report bias because they were drawn from administrative registers and have a 
negligible level of missingness. Third, we relied on a methodological approach that enabled 
us to account for unobserved parental characteristics shared by siblings. Unlike prior studies, 
which compared MAR- and naturally conceived children in the same families using random-
effects models, 
17-19
 we estimated fixed-effects models that fully control for unobserved 
parental characteristics shared by siblings, and are thus preferable when the aim is to isolate 
the effects of MAR from those of unobserved parental characteristics.
16
 Moreover, we 
included in the MAR group children who were conceived with treatments other than IVF. In 
prior studies, these children were included in the reference category of naturally conceived 
children.  
 
Our analysis has limitations that are important to note when considering the practical 
implications of the findings. First, although the use of the within-family approach minimized 
the confounding of unobserved parental characteristics in our estimates, it restricted our 
ability to generalize the results to all MAR-conceived children. A particular concern is that 
parents who have both MAR- and naturally conceived children are more likely to have used 
less invasive treatments, such as ovulation induction, that may not be as strongly associated 
with adverse birth outcomes, than more invasive treatments, such as IVF. Because we did not 
have access to the National Procedure Register, we could not reliably distinguish all IVF 
treatments from the less invasive treatments. A comparison with Hemminki et al.
20
 indicated 
that in our data we underestimated the percentage of IVF-conceived children by about  10%. 
As a robustness check we estimated the models separately for the group of IVF-conceived 
children (40% of total MAR births), and the results support the main study argument. For the 
same reason, we could not distinguish fresh from frozen embryo transfers in IVF/ICSI 
cycles.
23
 Whilst the fact that we could not analyze treatment types separately is a limitation, 
we believe that it is also justifiable to analyze MAR as a single category because there are a 
lot of common characteristics between couples who access different MAR treatments. For 
example, couples who seek any MAR treatment are unable to conceive naturally and suffer 
from sub-fertility, all treatment types involve some drug therapy, and undergoing any MAR 
treatment is a stressful process. Children who are conceived through any MAR treatment are 
more likely to be multiple birth and the first born. All these characteristics could negatively 
affect birth outcomes.  
9 
 
 
Second, we could not test whether the effects of MAR on birth outcomes vary according to 
the length of infertility, medication dose and number of treated cycles. Future work using 
larger samples and with longer follow-up should explore whether the effects of MAR on birth 
outcomes vary, for example, by the length of infertility. In addition, further analyses should 
evaluate whether the repercussions of MAR on child outcomes have changed over time (for 
example, single embryo transfer has become common practice resulting in a drop in multiple 
births)
2
. Finally, further within family fixed-effect analyses should aim to study the 
relationship between MAR treatments and longer term health and social outcomes. Third, the 
within-family analyses have lowered the precision of the estimates because they reduced the 
sample size, which could in turn mean that the parameters were not statistically significant; 
the within-family confidence intervals overlapped with those of the between-family 
estimates. However, the within-family associations for all four outcomes showed parameter 
estimates that were both statistically and substantially negligible.  
 
The fact that the within-family estimates are smaller than the between-family ones suggest 
that the association between MAR and adverse birth outcomes is confounded by unobserved 
factors related to both the probability of seeking MAR treatment to conceive and the 
probability of adverse birth outcomes. These unobserved factors could be parental underlying 
health, subfertility, psychological stress and genetic factors. Three other studies have looked 
at families with at least one MAR- and one naturally conceived child. Our results are not 
fully comparable to those of previous studies because we used fixed- (instead of random-) 
effects models, and we assigned children conceived with treatments other than IVF to the 
MAR (rather than the reference) category. Moreover, unlike in previous studies, we did not 
control for mediators like gestational age when analysing the association between MAR and 
birth weight/LBW. However, despite these differences, our study and these three other 
studies all suggest that any MAR-specific effect on birth outcomes (though statistically 
significant in two studies 
18,19
) is small, and is unlikely to be clinically relevant.   
 
The results also point to the importance of considering factors that vary across families and 
between siblings. In particular, MAR-conceived children are more likely than naturally 
conceived children to be the first-born child. Being the first-born is a known risk factor for 
adverse birth outcomes, and our results show that the effect of birth order is stronger than the 
effect of MAR in both the between- and within-family analyses. For example, the analyses 
for birth weight show that the effect of being the first-born rather than the second- or third-
born was, respectively, three and four times higher than the effect of MAR (Web Table 1). 
Moreover, in the within-family analyses, the association between MAR and birth outcomes 
changed substantially based on whether the MAR child was born before or after his/her 
naturally conceived sibling. These findings support the argument that the treatments per se 
have little or no effect on the risk of adverse birth outcomes, and that any effects that exist are 
considerably smaller than the effect of being the first-born. Yet the impact on birth outcomes 
of birth order has been much less discussed in the literature than the negative impact of 
MAR.   
 
The question of whether seeking MAR treatment to conceive increases the risk of adverse 
pregnancy outcomes is important given that the utilization of these techniques has been 
increasing strongly in virtually all advanced societies since the 1980s.
1,24
 Understanding these 
risks is essential for couples considering using MAR treatments to conceive, physicians 
advising patients about the risks of MAR, and public health authorities. Our results indicate 
that children born after MAR are, in absolute terms, at elevated risk of adverse birth 
10 
 
outcomes; but that this higher risk is likely attributable to factors other than the treatment 
itself. 
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Table 1 Birth outcomes and characteristics of women giving birth in Finland in 1995-2000, by mode of conception 
 
Overall population Within-family sample 
  NC (n=62,947) MAR (n=2,776) P value NC (n=620) MAR (n=625) P value 
Birth outcomes 
      
Birth weight in grams, mean (sd) 3551 (556) 3286 (694) p<0.0001 3594 (547) 3428 (665) p<0.0001 
Low birth weight (%) 3.5 12.8 p<0.0001 2.9 8.6 p<0.0001 
Gestational age in days , mean (sd) 278 (12) 271 (17) p<0.0001 278 (11) 275 (15) p<0.0001 
Preterm (%) 4.9 14.6 p<0.0001 4.8 9.4 0.002 
Covariates 
      
First-order birth (%) 37.7 61.6 p<0.0001 26.6 47.5 p<0.0001 
Maternal age  at birth, mean (sd) 29.6 (5) 32.0 (5) p<0.0001 31.0 (5) 31.0 (4) 0.671 
Household income decile, mean (sd) 5.3 (3) 6.3 (3) p<0.0001 5.9 (3) 6.2 (3) 0.04 
Household with tertiary education (%) 53.0 65.3 p<0.0001 66.8 68.5 0.593 
Parents married the year of the child's birth (%) 66.4 79.4 p<0.0001 82.9 81.6 0.619 
Mother smoked during pregnancy (%) 14.4 6.2 p<0.0001 4.2 5.8 0.253 
Multiple birth (%) 2.1 20.7 p<0.0001 1.0 10.9 p<0.0001 
Child sex: girl (%) 49.1 48.6 0.725 46.3 45.4 0.769 
Number of observations 65723   1245 
 Note: NC=naturally conceived; MAR=conceived with the help of Medically Assisted Reproduction methods. P values obtained through Chi Square test (for all categorical 
variables) and t test (for all continuous variables).  
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Table 2 MAR coefficients obtained by estimating between- (n=65,723) and within-family (n=1,245) linear models on the birth outcomes of women giving birth in 
Finland 1995-2000 (reference category: naturally conceived children) 
  
Baseline   P Value 95% CI 
Model 1 
= child 
sex + 
multiple 
birth 
P Value 95% CI 
Model 
2=Model 1+ 
child birth 
order 
 P Value 95% CI 
Model 
3=Model 2+ 
family 
characteristicsa 
P Value 95% CI 
Between family Birth weight (gr) -266 p<0.0001 -296 - -235 -98 p<0.0001 -124 - -72 -47 p<0.0001 -73 - -22 -60 p<0.0001 -86 - -34 
 
Gestational age 
(days) 
-6 p<0.0001 -7 - -5 -2 p<0.0001 -3 - -2 -2 p<0.0001 -3 - -1 -2 p<0.0001 -3 - -1 
 
LBW (percentage 
points) 
9.35 p<0.0001 7.88 - 10.81 2.24 p<0.0001 1.31 - 3.17 1.43 0.003 0.49 - 2.36 1.61 0.001 0.68 - 2.55 
  
Preterm  
(percentage 
points) 
9.75 p<0.0001 8.10 - 11.41 2.78 p<0.0001 1.71 - 3.86 2.01 p<0.0001 0.93 - 3.10 2.15 p<0.0001 1.07 - 3.24 
Within family 
(sibling fixed 
effects) 
Birth weight (gr) -137 p<0.0001 -189 - -85 -82 0.001 -132 - -32 -34 0.209 -88 - 19 -31 0.252 -85 - 22 
 
Gestational age 
(days) 
-2 p<0.0001 -4 - -1 -1 0.07 -2 – 0 -1 0.056 -3 - 0 -1 0.059 -3 - 0 
 
LBW  
(percentage 
points) 
4.66 p<0.0001 2.39 - 6.93 2.31 0.019 0.38 - 4.25 1.57 0.138 -0.51 - 3.65 1.42 0.18 -0.66 - 3.51 
 
Preterm  
(percentage 
points) 
4.04 0.003 1.36 - 6.73 2.03 0.107 -0.44 - 4.49 1.54 0.277 -1.24 - 4.31 1.56 0.278 -1.26 - 4.38 
Note: 
a 
Model 2 includes control for: birth order, maternal age at birth, smoking during pregnancy, household income decile. The between family model also includes 
adjustment for parents' marital status and for whether at least one of the two parents holds a tertiary education degree. Reference category: naturally conceived children  
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Table 3 Within-family MAR coefficients obtained by estimating linear models on the birth outcomes among women giving birth in Finland 1995-2000, by birth 
order of MAR vs. NC conceptions 
  
Baseline  P value Model 1 = child sex + multiple birth P value 
MAR followed by NC 
(n=744) 
Birth weight (gr) -224 p<0.0001 -163 p<0.0001 
 
Gestational age (days) -2 0.036 0 0.792 
 
LBW 5.49 p<0.0001 2.72 0.029 
  Preterm  4.93 0.007 2.11 0.195 
NC followed by MAR 
(n=464) 
Birth weight (gr) 8 0.845 58 0.183 
 
Gestational age (days) -4 0.001 -2 0.019 
 
LBW 3.36 0.061 1.36 0.398 
  Preterm  2.31 0.29 1.30 0.522 
Note: NC=naturally conceived; MAR=conceived through the help of Medically Assisted Reproduction. Reference category: naturally conceived children 
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Figure 1 Mean birth weight for MAR children (reference: naturally conceived)  from estimating between- and within-family models for women giving birth in 
Finland 1995-2000 (Table 2), with 95% confidence intervals 
 
 
Figure 2 Mean gestational age for MAR children (reference: naturally conceived)  from between- and within-family models for women giving birth in Finland 
1995-2000 (Table 2), with 95% confidence intervals 
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Figure 3 Percentage change in the probability of LBW for MAR children (reference: naturally conceived) from between- and within-family models for women 
giving birth in Finland 1995-2000 (Table 2), with 95% confidence intervals 
 
 
Figure 4 Percentage change in the probability of preterm birth for MAR (reference: naturally conceived)  children from between- and within-family models for 
women giving birth in Finland 1995-2000 (Table 2), with 95% confidence intervals 
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Figure 5 Mean birth weight for MAR children from within-family models, by birth order of MAR and naturally conceived siblings for women giving birth in 
Finland 1995-2000 (Table 3), with 95% confidence intervals 
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